Response to imatinib mesylate in a patient with idiopathic hypereosinophilic syndrome associated with cyclic eosinophil oscillations

A 26-year-old man with idiopathic hypereosinophilic syndrome (HES) was treated with imatinib mesylate following a 5-year history of prednisolone therapy. The patient had hypereosinophilia (absolute eosinophil counts >1500/microL) occurring in cyclic oscillations as well as histologically diagnose...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of hematology 2005-05, Vol.81 (4), p.310-314
Hauptverfasser:	Imashuku, Shinsaku, Kakazu, Naoki, Ueda, Ikuyo, Morimoto, Akira, Harada, Hironori, Teramura, Tomoko, Tamura, Shinichi, Fukushima-Nakase, Yoko, Kuroda, Hiroshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Agents - pharmacology Benzamides DNA Mutational Analysis Humans Hypereosinophilic Syndrome - drug therapy Imatinib Mesylate Male Piperazines - pharmacology Pyrimidines - pharmacology Receptors, Platelet-Derived Growth Factor - genetics Recurrence Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!